# US 2025/0367385 A1 · Medical injections and related devices and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0367385 A1
- Document ID: US20250367385A1
- Status: Published application
- Kind: A1
- Application number: 19/206,132
- Filed: 2025-05-13
- Published: 2025-12-04
- Earliest claimed: 2024-05-14
- Assignees: Gilead Sciences, Inc.
- Applicants: Gilead Sciences, Inc.
- Inventors: Stephan Edward Augustyn; Berk Besen; Stuart Curtis; Rosemary Victoria Earl; Walter Goodwin; Matthew Robert Hiskey; William James Kirby; Finlay Knops-McKim; Daniel Milton Meruz; James Paul Oberhauser; Alasdair Young
- Web page: https://patentgrep.com/patent/US20250367385A1

## CPC

- A61M 5/3157: {Means providing feedback signals when administration is completed (A61M5/20 takes precedence)}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61M 5/2046: {Media being expelled from injector by gas generation, e.g. explosive charge}
- A61M 2005/2013: {triggering of discharging means by contact of injector with patient body}
- A61M 2005/31588: {electrically driven}
- A61M 2205/3317: Electromagnetic, inductive or dielectric measuring means
- A61M 2205/3368: Temperature
- A61M 2205/581: by audible feedback
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Systems, devices, and methods include an autoinjector including a housing; a needle arranged at a distal end of the housing; a container disposed within the housing and configured to contain medicament; and a plunger slidably disposed within the container. A plunger rod is configured to push the plunger through the container to dispense the medicament through the needle when the container contains medicament. The plunger rod includes one or more conductive regions. A mechanism is configured so that a dispensing movement of the plunger rod causes the mechanism to generate a first electrical signal from at least one of the one or more conductive regions. A first sensor is configured to detect the first electrical signal generated by the mechanism.

## Claims

### Claim 1

An autoinjector comprising:
a housing;
a needle arranged at a distal end of the housing;
a container disposed within the housing and configured to contain medicament;
a plunger slidably disposed within the container;
a plunger rod configured to push the plunger through the container to dispense the medicament through the needle when the container contains medicament, wherein the plunger rod comprises one or more conductive regions;
a first conductive contact configured to contact a portion of the plunger rod, wherein a dispensing movement of the plunger rod generates a first electrical signal upon contacting said first conductive contact and at least one of said one or more conductive regions of the plunger rod; and
a first sensor configured to detect said first electrical signal as the plunger rod moves.

### Claim 2 (depends on 1)

The autoinjector of claim 1, wherein the first electrical signal is indicative of dose progression.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

The autoinjector of claim 1, wherein the medicament comprises lenacapavir or a pharmaceutically accepted salt thereof.

### Claim 5 (depends on 1)

The autoinjector of claim 1, wherein the autoinjector further comprises a gas canister assembly configured to release pressurized gas which, when released, provides a force acting on the plunger rod to push the plunger through the container.

### Claim 6 (depends on 1)

The autoinjector of claim 1, wherein the first conductive contact comprises a lock ring contact configured to be attached to a lock ring.

### Claim 7 (depends on 6)

The autoinjector of claim 6, wherein the lock ring contact and/or the lock ring comprises an opening configured to provide a pathway for the dispensing movement of the plunger rod, and wherein the lock ring contact comprises one or more deflectable contacts disposed around said opening and configured to contact at least one of said one or more conductive regions during the dispensing movement of the plunger rod.

### Claim 8

(canceled)

### Claim 9 (depends on 0)

The autoinjector of claim 0, wherein the plunger rod comprises a plurality of conductive regions and is configured to generate a plurality of electrical signals during the dispensing movement of the plunger rod.

### Claim at position 10

10-11. (canceled)

### Claim 12 (depends on 9)

The autoinjector of claim 9, wherein a first conductive region of the plurality of conductive regions is configured to indicate dose start of the medicament, and/or wherein a last conductive region of the plurality of conductive regions is configured to indicate dose end of the medicament.

### Claim at position 12

13-16. (canceled)

### Claim 17 (depends on 0)

The autoinjector of claim 0, further comprising:
an audible clicker configured to produce one or more audible clicks during the dispensing movement of the plunger rod.

### Claim 18 (depends on 17)

The autoinjector of claim 17, wherein the audible clicker comprises a ring surrounding the plunger rod, and wherein the ring comprises a deflectable protrusion configured to contact the plunger rod and produce the one or more audible clicks.

### Claim 19 (depends on 18)

The autoinjector of claim 18, wherein the plunger rod comprises a ridged surface configured to cause the deflectable protrusion of the audible clicker to deflect during the dispensing movement of the plunger rod.

### Claim at position 16

20-21. (canceled)

### Claim 22 (depends on 1)

The autoinjector of claim 1, wherein the first sensor comprises a voltage sensor or a resistance sensor.

### Claim 23 (depends on 1)

The autoinjector of claim 1, wherein the first sensor is disposed on a surface of a printed circuit board disposed between a proximal end and a distal end of the housing.

### Claim 24 (depends on 1)

The autoinjector of claim 1, wherein the first sensor is further configured to detect a second electrical signal generated by applying an insertion force to insert the needle into a user.

### Claim at position 20

25-26. (canceled)

### Claim 27 (depends on 1)

The autoinjector of claim 1, wherein a second sensor is disposed between a proximal end and a distal end of the housing, and wherein the second sensor is configured to detect an ambient temperature in proximity to the container.

### Claim at position 22

28-31. (canceled)

### Claim 32

A method of detecting a dispensing movement of a plunger rod within an autoinjector, the method comprising:
detecting, using a first sensor, one or more electrical signals of a first conductive contact as the plunger rod moves during the dispensing movement, wherein the plunger rod comprises one or more conductive regions, and
wherein the dispensing movement of the plunger rod provides electrical communication between one or more conductive regions and the first conductive contact causing the first conductive contact to generate the one or more electrical signals.

### Claim 33

(canceled)

### Claim 34 (depends on 32)

The method of claim 32, wherein the plunger rod comprises a plurality of conductive regions and to the method further comprises generating a plurality of electrical signals during the dispensing movement of the plunger rod.

### Claim 35

(canceled)

### Claim 36 (depends on 34)

The method of claim 34, wherein a first conductive region of the plurality of conductive regions is configured to indicate dose start of a medicament, and/or wherein a last conductive region of the plurality of conductive regions is configured to indicate dose end of the medicament.

### Claim 37

(canceled)

### Claim 38 (depends on 32)

The method of claim 32, wherein a lock ring contact is configured to generate a plurality of electrical signals during the dispensing movement of the plunger rod.

### Claim 39 (depends on 38)

The method of claim 38, wherein the lock ring contact comprises an opening and one or more deflectable contacts disposed around said opening, and wherein during the dispensing movement of the plunger rod, the one or more deflectable contacts contact each conductive region.

### Claim 40

(canceled)

### Claim 41 (depends on 32)

The method of claim 32, wherein the autoinjector further comprises an audible clicker configured to produce one or more audible clicks during the dispensing movement of the plunger rod.

### Claim 42 (depends on 41)

The method of claim 41, wherein the audible clicker comprises a ring surrounding the plunger rod, and wherein the ring comprises a deflectable protrusion configured to contact the plunger rod and produce the one or more audible clicks.

### Claim 43 (depends on 42)

The method of claim 42, wherein the plunger rod comprises a ridged surface configured to contact the deflectable protrusion of the audible clicker, and wherein during the dispensing movement of the plunger rod, ridges of the ridged surface cause the deflectable protrusion to deflect.

### Claim at position 35

44-47. (canceled)

### Claim 48 (depends on 32)

The method of claim 32, further comprising detecting, by the first sensor, a second electrical signal generated by applying an insertion force to insert a needle into a user.

### Claim 49 (depends on 32)

The method of claim 32, wherein a second sensor is disposed between a proximal end and a distal end of the housing, and wherein the method further comprises detecting, by the second sensor, a second electrical signal generated by applying an insertion force to insert a needle into a user.

### Claim at position 38

50-52. (canceled)

### Claim 53 (depends on 32)

The method of claim 32, further comprising sending, via a wireless transfer protocol module, signals from a first sensor, if present, and a second sensor, if present, to a mobile device.

### Claim 54 (depends on 53)

The method of claim 53, further comprising displaying information about the dispensing movement on the mobile device.

### Claim 55 (depends on 32)

The method of claim 32, further comprising measuring a temperature of medicament within the autoinjector or an ambient temperature within the autoinjector using a temperature sensor.

### Claim 56

(canceled)

### Claim 57 (depends on 55)

The method of claim 55, further comprising displaying the temperature of the medicament or the ambient temperature on a mobile device; indicating that the temperature of the medicament or the ambient temperature is above a threshold temperature for use of the autoinjector; or both.

### Claim 58 (depends on 1)

A composition comprising lenacapavir or a pharmaceutically accepted salt thereof for use in the prevention or treatment of HIV, wherein the composition is administered via the autoinjector of claim 1.

### Claim 59 (depends on 1)

Use of lenacapavir or a pharmaceutically accepted salt thereof for the manufacture of a medicament for the prevention or treatment of HIV, wherein the prevention or treatment comprises administering the medicament via the autoinjector of claim 1.
